Sales & Marketing Key payer backs Ultragenyx' rare rickets drug at $200,000 pe... Express Scripts' Miller backs "responsible" price
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face